The Cologne ECMM Excellence Center : A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections
© 2024. The Author(s)..
The European Confederation of Medical Mycology (ECMM), formed due to the surge in invasive fungal infections (IFI), initiated the Excellence Centers program in 2016 to guide stakeholders to leading medical mycology sites. This report focuses on the Cologne ECMM Excellence Center, recognized with Diamond status for active global involvement in 2017. The center offers free consultation via email and phone, responding within 24 h for life-threatening IFI, collecting data on origin, pathogens, infection details, and more. Over two years, 189 requests were received globally, predominantly from Germany (85%), mainly involving Aspergillus spp., Mucorales, and Candida spp. Fungal mixed infections occurred in 4% of cases. The center's service effectively addresses IFI challenges, advocating for a comprehensive study encompassing all ECMM Excellence Centers to enhance global mycological care. Proactive expansion of consultancy platforms is crucial, with future analyses needed to assess expert advice's impact on patient outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:189 |
|---|---|
| Enthalten in: |
Mycopathologia - 189(2024), 2 vom: 11. März, Seite 25 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salmanton-García, Jon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antifungal Agents |
|---|
| Anmerkungen: |
Date Completed 13.03.2024 Date Revised 14.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11046-023-00822-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36956197X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36956197X | ||
| 003 | DE-627 | ||
| 005 | 20240314235441.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240312s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11046-023-00822-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1329.xml |
| 035 | |a (DE-627)NLM36956197X | ||
| 035 | |a (NLM)38466469 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salmanton-García, Jon |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Cologne ECMM Excellence Center |b A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.03.2024 | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a The European Confederation of Medical Mycology (ECMM), formed due to the surge in invasive fungal infections (IFI), initiated the Excellence Centers program in 2016 to guide stakeholders to leading medical mycology sites. This report focuses on the Cologne ECMM Excellence Center, recognized with Diamond status for active global involvement in 2017. The center offers free consultation via email and phone, responding within 24 h for life-threatening IFI, collecting data on origin, pathogens, infection details, and more. Over two years, 189 requests were received globally, predominantly from Germany (85%), mainly involving Aspergillus spp., Mucorales, and Candida spp. Fungal mixed infections occurred in 4% of cases. The center's service effectively addresses IFI challenges, advocating for a comprehensive study encompassing all ECMM Excellence Centers to enhance global mycological care. Proactive expansion of consultancy platforms is crucial, with future analyses needed to assess expert advice's impact on patient outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antifungal diagnosis | |
| 650 | 4 | |a Antifungal treatment | |
| 650 | 4 | |a Clinical management | |
| 650 | 4 | |a Consultation | |
| 650 | 4 | |a Medical mycology | |
| 650 | 7 | |a Antifungal Agents |2 NLM | |
| 700 | 1 | |a Koehler, Philipp |e verfasserin |4 aut | |
| 700 | 1 | |a Grothe, Jan-Hendrik |e verfasserin |4 aut | |
| 700 | 1 | |a Mellinghoff, Sibylle C |e verfasserin |4 aut | |
| 700 | 1 | |a Sal, Ertan |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, Michaela |e verfasserin |4 aut | |
| 700 | 1 | |a Stemler, Jannik |e verfasserin |4 aut | |
| 700 | 1 | |a Cornely, Oliver A |e verfasserin |4 aut | |
| 700 | 1 | |a Sprute, Rosanne |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mycopathologia |d 1975 |g 189(2024), 2 vom: 11. März, Seite 25 |w (DE-627)NLM000021288 |x 1573-0832 |7 nnns |
| 773 | 1 | 8 | |g volume:189 |g year:2024 |g number:2 |g day:11 |g month:03 |g pages:25 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11046-023-00822-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 189 |j 2024 |e 2 |b 11 |c 03 |h 25 | ||